
Keywords: ژن سرکوب کننده تومور; Molecular Classification; Genomic Profiling; Outcome; Targeted Therapies; CI; confidence interval; CNV; copy number variations; EGFR; epidermal growth factor receptor; EpCAM; epithelial cellular adhesion molecule; FDR; false discovery rate; FF; fresh-froz